Daré Bioscience, Inc.
DARE
$2.78
-$0.14-4.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.68M | -4.05M | -3.60M | -7.20M | -28.87M |
| Total Depreciation and Amortization | 189.60K | 42.30K | 45.90K | 45.50K | 39.70K |
| Total Amortization of Deferred Charges | 17.50K | 700.00 | 700.00 | 700.00 | 700.00 |
| Total Other Non-Cash Items | 2.65M | 3.59M | 2.36M | 2.41M | 2.41M |
| Change in Net Operating Assets | 5.56M | 5.81M | -6.82M | -5.31M | -3.13M |
| Cash from Operations | 6.74M | 5.39M | -8.01M | -10.06M | -29.55M |
| Capital Expenditure | -723.00K | -573.00K | -617.50K | -921.90K | -636.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -723.00K | -573.00K | -617.50K | -921.90K | -636.70K |
| Total Debt Issued | 561.70K | 561.70K | 561.70K | 601.20K | 601.20K |
| Total Debt Repaid | -566.00K | -579.20K | -592.40K | -601.20K | -534.40K |
| Issuance of Common Stock | 674.70K | 453.60K | 1.18M | 9.29M | 9.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.00K | -2.20K | 4.72M | 4.72M | 4.72M |
| Cash from Financing | 666.40K | 433.80K | 5.88M | 14.02M | 14.35M |
| Foreign Exchange rate Adjustments | -15.60K | -67.90K | 56.90K | 19.00K | -26.80K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | 6.66M | 5.19M | -2.70M | 3.05M | -15.86M |